Haemonetics Corporation
NYSEHaemonetics Corporation enters its May 7 earnings call in an unusual spot: short sellers have been cutting exposure for six weeks, options traders are positioned bullishly, and yet the stock trades at a near-50% discount to the Street's mean price target — a gap that reflects lingering scepticism after two brutal post-earnings drops. The short interest story has been the standout…
Snapshot as of 9 May 2026
Haemonetics Corporation enters its May 7 earnings call in an unusual spot: short sellers have been cutting exposure for six weeks, options traders are positioned bullishly, and yet the stock trades at a near-50%…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HAE — free to start on ORTEX.
Sign up for free →Open HAE on ORTEX